292 related articles for article (PubMed ID: 20694964)
21. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
[TBL] [Abstract][Full Text] [Related]
22. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
23. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
24. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
Gentile S
Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
[TBL] [Abstract][Full Text] [Related]
25. Low Apgar scores in neonates with prenatal antidepressant exposure.
Nebhinani N; Soni S
Br J Psychiatry; 2013 Jun; 202():464. PubMed ID: 23732937
[No Abstract] [Full Text] [Related]
26. Antidepressant medication treatment during pregnancy: prevalence of use, clinical implications, and alternatives.
Freeman MP
J Clin Psychiatry; 2011 Jul; 72(7):977-8. PubMed ID: 21824457
[No Abstract] [Full Text] [Related]
27. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
Olivier JD; Åkerud H; Sundström Poromaa I
Eur J Pharmacol; 2015 Apr; 753():257-62. PubMed ID: 25094036
[TBL] [Abstract][Full Text] [Related]
28. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
[TBL] [Abstract][Full Text] [Related]
29. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
[TBL] [Abstract][Full Text] [Related]
30. Discontinuation syndrome following late pregnancy exposure to antidepressants.
Koren G
Arch Pediatr Adolesc Med; 2004 Apr; 158(4):307-8. PubMed ID: 15066865
[No Abstract] [Full Text] [Related]
31. Neonates born to mothers using antidepressant drugs.
Zuccotti GV; Fabiano V; Manfredini V
Early Hum Dev; 2012 May; 88 Suppl 2():S84-5. PubMed ID: 22633523
[No Abstract] [Full Text] [Related]
32. Neonatal morbidity due to maternal use of two antidepressant drugs.
Jwa S; Wada Y; Yamamoto M; Sumida Y
Pediatr Int; 2018 Jan; 60(1):87-88. PubMed ID: 29235219
[No Abstract] [Full Text] [Related]
33. Treating depression in pregnancy.
Robert E
N Engl J Med; 1996 Oct; 335(14):1056-8. PubMed ID: 8793933
[No Abstract] [Full Text] [Related]
34. [SSRI antidepressant use during pregnancy and the assessment of the risk-benefit ratio].
Weisskopf E; Fumeaux CJ; Bickle Graz M; Harari MM; Epiney M; Tolsa CB; Rouiller S; Tolsa JF; Eap CB; Vial Y; Csajka C; Panchaud A
Rev Med Suisse; 2016 Mar; 12(510):561-6. PubMed ID: 27149719
[TBL] [Abstract][Full Text] [Related]
35. The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge.
Jerome L
Can J Psychiatry; 2000 Dec; 45(10):940. PubMed ID: 11190371
[No Abstract] [Full Text] [Related]
36. SSRI use during pregnancy and risk of stillbirth and neonatal mortality.
Jimenez-Solem E; Andersen JT; Petersen M; Broedbaek K; Lander AR; Afzal S; Torp-Pedersen C; Poulsen HE
Am J Psychiatry; 2013 Mar; 170(3):299-304. PubMed ID: 23361562
[TBL] [Abstract][Full Text] [Related]
37. Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.
Bracken MB
Eur J Epidemiol; 2015 Nov; 30(11):1217-8. PubMed ID: 26518772
[No Abstract] [Full Text] [Related]
38. Response to: Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.
Dolk H; Wemakor A
Eur J Epidemiol; 2015 Nov; 30(11):1219-21. PubMed ID: 26620807
[No Abstract] [Full Text] [Related]
39. Prenatal exposure to antidepressants: how safe are they?
Steiner M
Am J Psychiatry; 2012 Nov; 169(11):1130-2. PubMed ID: 23128917
[No Abstract] [Full Text] [Related]
40. A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.
Stohl H; Kohm AD; Dossett E
J Neonatal Perinatal Med; 2016; 9(1):1-5. PubMed ID: 27002264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
